Global Nasal Swab Self Test Kits Market Research Report 2023-2029 - Industry Today
| 086060 Stock | KRW 3,415 65.00 1.94% |
About 55% of GeneBioTech's investors are presently thinking to get in. The analysis of current outlook of investing in GeneBioTech Co suggests that some traders are interested regarding GeneBioTech's prospects. The current market sentiment, together with GeneBioTech's historical and current headlines, can help investors time the market. In addition, many technical investors use GeneBioTech stock news signals to limit their universe of possible portfolio assets.
GeneBioTech |
Global Nasal Swab Self Test Kits Market Research Report 2023-2029 Industry Today
Read at news.google.com
 |
GeneBioTech Fundamental Analysis
We analyze GeneBioTech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GeneBioTech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GeneBioTech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
GeneBioTech Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with GeneBioTech stock to make a market-neutral strategy. Peer analysis of GeneBioTech could also be used in its relative valuation, which is a method of valuing GeneBioTech by comparing valuation metrics with similar companies.
Peers
GeneBioTech Related Equities
| 058470 | LEENO Industrial | 6.85 | ||||
| 007530 | Youngsin Metal | 3.89 | ||||
| 025750 | Hansol Homedeco | 0.16 | ||||
| 034810 | Haesung Industrial | 0.17 | ||||
| 115480 | CU Medical | 0.58 | ||||
| 013580 | Kyeryong Construction | 2.02 | ||||
| 009900 | Myoung Shin | 2.03 |
Complementary Tools for GeneBioTech Stock analysis
When running GeneBioTech's price analysis, check to measure GeneBioTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneBioTech is operating at the current time. Most of GeneBioTech's value examination focuses on studying past and present price action to predict the probability of GeneBioTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneBioTech's price. Additionally, you may evaluate how the addition of GeneBioTech to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |